Investment Analysts’ updated eps estimates for Monday, August 7th:

Arbutus Biopharma Corporation (NASDAQ:ABUS) had its buy rating reaffirmed by analysts at Chardan Capital.

BT Group PLC (NYSE:BT) had its buy rating reiterated by analysts at Numis Securities Ltd. The firm currently has a GBX 390 ($5.14) target price on the stock.

Blue Buffalo Pet Products (NASDAQ:BUFF) had its buy rating reissued by analysts at Susquehanna Bancshares Inc.

Corium International (NASDAQ:CORI) had its buy rating reaffirmed by analysts at Jefferies Group LLC. They currently have a $10.00 price target on the stock.

Ford Motor (NYSE:F) had its neutral rating reiterated by analysts at Jefferies Group LLC.

Aevi Genomic Medicine (NASDAQ:GNMX) had its hold rating reissued by analysts at Jefferies Group LLC. The firm currently has a $1.50 target price on the stock.

Gener8 Maritime (NASDAQ:GNRT) had its buy rating reiterated by analysts at Jefferies Group LLC. The firm currently has a $10.00 price target on the stock.

ImmunoGen (NASDAQ:IMGN) had its buy rating reiterated by analysts at Jefferies Group LLC. They currently have a $9.00 target price on the stock.

Monster Beverage Corporation (NASDAQ:MNST) had its hold rating reaffirmed by analysts at Susquehanna Bancshares Inc.

Netcall plc (LON:NET) had its corporate rating reissued by analysts at FinnCap. The firm currently has a GBX 70 ($0.92) price target on the stock.

Petrofac Limited (LON:PFC) had its buy rating reaffirmed by analysts at Kepler Capital Markets. They currently have a GBX 700 ($9.23) target price on the stock.

Receive News & Ratings for Arbutus Biopharma Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arbutus Biopharma Corporation and related companies with MarketBeat.com's FREE daily email newsletter.